{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:35:21Z","timestamp":1777592121532,"version":"3.51.4"},"reference-count":92,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2014.00213","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T08:21:23Z","timestamp":1400055683000},"source":"Crossref","is-referenced-by-count":20,"title":["Genetically Modified Organisms and Visceral Leishmaniasis"],"prefix":"10.3389","volume":"5","author":[{"given":"Rudra","family":"Chhajer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl","key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/hv.7.0.14556","article-title":"Vaccines for leishmaniasis: from proteome to vaccine candidates","volume":"7","author":"Schroeder","year":"2011","journal-title":"Hum Vaccin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/j.1469-0691.2011.03610.x","article-title":"Visceral leishmaniasis: immunology and prospects for a vaccine","volume":"17","author":"Kaye","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"B4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s11096-011-9544-8","article-title":"A rare case of visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy","volume":"33","author":"Kumar","year":"2011","journal-title":"Int J Clin Pharm"},{"key":"B5","doi-asserted-by":"publisher","first-page":"892817","DOI":"10.1155\/2012\/892817","article-title":"Development of vaccines against visceral leishmaniasis","volume":"2012","author":"Evans","year":"2012","journal-title":"J Trop Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fimmu.2012.00099","article-title":"Vaccine development against Leishmania donovani","volume":"3","author":"Das","year":"2012","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.vaccine.2010.02.089","article-title":"Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE","volume":"28","author":"Trigo","year":"2010","journal-title":"Vaccine"},{"key":"B9","first-page":"942","article-title":"Progress towards a Leishmania vaccine","volume":"27","author":"Tabbara","year":"2006","journal-title":"Saudi Med J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4161\/hv.7.11.17752","article-title":"Leishmaniasis","volume":"7","author":"Kedzierski","year":"2011","journal-title":"Hum Vaccin"},{"key":"B11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4161\/hv.5.5.7607","article-title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","volume":"5","author":"Okwor","year":"2009","journal-title":"Hum Vaccin"},{"key":"B12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00005-008-0010-9","article-title":"Live attenuated Leishmania vaccines: a potential strategic alternative","volume":"56","author":"Silvestre","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/138945009787581195","article-title":"Genomic databases and the search of protein targets for protozoan parasites","volume":"10","author":"Timmers","year":"2009","journal-title":"Curr Drug Targets"},{"key":"B14","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1016\/S0021-9258(18)42896-7","article-title":"A sequence insertion targeting vector for Leishmania enrietti","volume":"267","author":"Tobin","year":"1992","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/jac\/dkp206","article-title":"Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening","volume":"64","author":"Singh","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"B16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1073\/pnas.88.3.864","article-title":"Homologous recombination in Leishmania enrietti","volume":"88","author":"Tobin","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B17","doi-asserted-by":"publisher","first-page":"30840","DOI":"10.1074\/jbc.271.48.30840","article-title":"Creation of homozygous mutants of Leishmania donovani with single targeting constructs","volume":"271","author":"Hwang","year":"1996","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molbiopara.2010.10.008","article-title":"A rapid, efficient and economical method for generating leishmanial gene targeting constructs","volume":"175","author":"Fulwiler","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1093\/nar\/25.21.4278","article-title":"Parameters controlling the rate of gene targeting frequency in the protozoan parasite Leishmania","volume":"25","author":"Papadopoulou","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4161\/bbug.2.6.18205","article-title":"The genetic toolbox for Leishmania parasites","volume":"2","author":"Roberts","year":"2011","journal-title":"Bioeng Bugs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4161\/hv.6.1.10396","article-title":"Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria","volume":"6","author":"Hoffman","year":"2010","journal-title":"Hum Vaccin"},{"key":"B22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4161\/hv.6.1.9654","article-title":"Genetically engineered, attenuated whole-cell vaccine approaches for malaria","volume":"6","author":"Vaughan","year":"2010","journal-title":"Hum Vaccin"},{"issue":"Suppl","key":"B23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4161\/hv.7.0.14557","article-title":"Arrested Plasmodium liver stages as experimental anti-malaria vaccines","volume":"7","author":"Matuschewski","year":"2011","journal-title":"Hum Vaccin"},{"key":"B24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature03188","article-title":"Genetically modified Plasmodium parasites as a protective experimental malaria vaccine","volume":"433","author":"Mueller","year":"2005","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"13004","DOI":"10.1073\/pnas.0906387106","article-title":"Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design","volume":"106","author":"Vanbuskirk","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1016\/j.vaccine.2013.08.007","article-title":"First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers","volume":"31","author":"Spring","year":"2013","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1746-6148-8-57","article-title":"Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics","volume":"8","author":"Li","year":"2012","journal-title":"BMC Vet Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1423-0127-20-37","article-title":"Current progress in dengue vaccines","volume":"20","author":"Wan","year":"2013","journal-title":"J Biomed Sci"},{"key":"B29","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4269\/ajtmh.2004.71.811","article-title":"Genetically modified, live attenuated dengue virus type 3 vaccine candidates","volume":"71","author":"Blaney","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/GRF.0b013e31824df256","article-title":"Measles, mumps, and rubella","volume":"55","author":"White","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4161\/hv.18757","article-title":"Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic","volume":"8","author":"Lopez-Macias","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"20120200","DOI":"10.1098\/rstb.2012.0200","article-title":"The antigenic evolution of influenza: drift or thrift?","volume":"368","author":"Wikramaratna","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e62496","DOI":"10.1371\/journal.pone.0062496","article-title":"Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness","volume":"8","author":"Vemula","year":"2013","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1016\/j.vaccine.2013.07.004","article-title":"The genetically modified suilysin, rSLY(P353L), provides a candidate vaccine that suppresses proinflammatory response and reduces fatality following infection with Streptococcus suis","volume":"31","author":"Du","year":"2013","journal-title":"Vaccine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.copbio.2012.03.007","article-title":"Recombinant live vaccine candidates against tuberculosis","volume":"23","author":"Kaufmann","year":"2012","journal-title":"Curr Opin Biotechnol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1517\/14712598.2012.721768","article-title":"An update on vaccines for tuberculosis \u00e2\u20ac\u201c there is more to it than just waning of BCG efficacy with time","volume":"12","author":"Romano","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1586\/14760584.5.4.483","article-title":"Live attenuated oral cholera vaccines","volume":"5","author":"Ryan","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1586\/erv.09.137","article-title":"Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009","volume":"8","author":"Chowdhury","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/cid\/cir141","article-title":"Oral vaccines against cholera","volume":"52","author":"Shin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jprot.2011.05.005","article-title":"Contribution of proteomics of Leishmania spp. to the understanding of differentiation, drug resistance mechanisms, vaccine and drug development","volume":"74","author":"Paape","year":"2011","journal-title":"J Proteomics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23668","DOI":"10.1074\/jbc.M402042200","article-title":"Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants","volume":"279","author":"Roberts","year":"2004","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00726-007-0537-9","article-title":"Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas\u00e2\u20ac\u2122 disease, and leishmaniasis","volume":"33","author":"Heby","year":"2007","journal-title":"Amino Acids"},{"key":"B43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molbiopara.2009.01.001","article-title":"Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB\/c mice","volume":"165","author":"Reguera","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1074\/jbc.274.6.3781","article-title":"Ornithine decarboxylase gene deletion mutants of Leishmania donovani","volume":"274","author":"Jiang","year":"1999","journal-title":"J Biol Chem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1128\/IAI.01236-08","article-title":"Leishmania donovani ornithine decarboxylase is indispensable for parasite survival in the mammalian host","volume":"77","author":"Boitz","year":"2009","journal-title":"Infect Immun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.exppara.2011.02.020","article-title":"Generating knock-in parasites: integration of an ornithine decarboxylase transgene into its chromosomal locus in Leishmania donovani","volume":"128","author":"Roberts","year":"2011","journal-title":"Exp Parasitol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1128\/IAI.00073-11","article-title":"Spermidine synthase is required for virulence of Leishmania donovani","volume":"79","author":"Gilroy","year":"2011","journal-title":"Infect Immun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1074\/jbc.M110118200","article-title":"S-adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducers","volume":"277","author":"Roberts","year":"2002","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1432-1033.1993.tb18348.x","article-title":"Phenotype of recombinant Leishmania donovani and Trypanosoma cruzi which over-express trypanothione reductase. Sensitivity towards agents that are thought to induce oxidative stress","volume":"218","author":"Kelly","year":"1993","journal-title":"Eur J Biochem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/emboj\/16.10.2590","article-title":"Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages","volume":"16","author":"Dumas","year":"1997","journal-title":"EMBO J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1073\/pnas.95.9.5311","article-title":"Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival","volume":"95","author":"Tovar","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B52","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1046\/j.1365-2958.1998.00968.x","article-title":"Evidence that trypanothione reductase is an essential enzyme in Leishmania by targeted replacement of the tryA gene locus","volume":"29","author":"Tovar","year":"1998","journal-title":"Mol Microbiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1515\/BC.2011.222","article-title":"Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani","volume":"392","author":"Saudagar","year":"2011","journal-title":"Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molbiopara.2006.02.015","article-title":"Leishmania donovani singly deficient in HGPRT, APRT or XPRT are viable in vitro and within mammalian macrophages","volume":"148","author":"Boitz","year":"2006","journal-title":"Mol Biochem Parasitol"},{"issue":"Pt B","key":"B55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/978-1-4684-1248-2_86","article-title":"Adenine phosphoribosyltransferase-deficient Leishmania donovani","volume":"195","author":"Kaur","year":"1986","journal-title":"Adv Exp Med Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"34403","DOI":"10.1074\/jbc.274.48.34403","article-title":"Xanthine phosphoribosyltransferase from Leishmania donovani. Molecular cloning, biochemical characterization, and genetic analysis","volume":"274","author":"Jardim","year":"1999","journal-title":"J Biol Chem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.molbiopara.2011.08.006","article-title":"IMP dehydrogenase deficiency in Leishmania donovani causes a restrictive growth phenotype in promastigotes but is not essential for infection in mice","volume":"180","author":"Fulwiler","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7626","DOI":"10.1074\/jbc.M111.307884","article-title":"Adenine aminohydrolase from Leishmania donovani: unique enzyme in parasite purine metabolism","volume":"287","author":"Boitz","year":"2012","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","first-page":"16084","DOI":"10.1074\/jbc.M600188200","article-title":"A conditional mutant deficient in hypoxanthine-guanine phosphoribosyltransferase and xanthine phosphoribosyltransferase validates the purine salvage pathway of Leishmania donovani","volume":"281","author":"Boitz","year":"2006","journal-title":"J Biol Chem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.1074\/jbc.M112.431486","article-title":"Adenylosuccinate synthetase and adenylosuccinate lyase deficiencies trigger growth and infectivity deficits in Leishmania donovani","volume":"288","author":"Boitz","year":"2013","journal-title":"J Biol Chem"},{"key":"B61","doi-asserted-by":"publisher","first-page":"20930","DOI":"10.1074\/jbc.M111.228213","article-title":"The Leishmania donovani UMP synthase is essential for promastigote viability and has an unusual tetrameric structure that exhibits substrate-controlled oligomerization","volume":"286","author":"French","year":"2011","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","first-page":"12759","DOI":"10.1074\/jbc.M112.346502","article-title":"Genetic dissection of pyrimidine biosynthesis and salvage in Leishmania donovani","volume":"287","author":"Wilson","year":"2012","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","first-page":"29954","DOI":"10.1074\/jbc.M113.478826","article-title":"Substrate inhibition of uracil phosphoribosyltransferase by uracil can account for the uracil growth sensitivity of Leishmania donovani pyrimidine auxotrophs","volume":"288","author":"Soysa","year":"2013","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/IAI.70.1.62-68.2002","article-title":"Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination","volume":"70","author":"Papadopoulou","year":"2002","journal-title":"Infect Immun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","article-title":"Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs","volume":"31","author":"Fiuza","year":"2013","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.4049\/jimmunol.1202801","article-title":"Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB\/c mice","volume":"190","author":"Dey","year":"2013","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2958.2012.08183.x","article-title":"Deletion of mitochondrial associated ubiquitin fold modifier protein Ufm1 in Leishmania donovani results in loss of beta-oxidation of fatty acids and blocks cell division in the amastigote stage","volume":"86","author":"Gannavaram","year":"2012","journal-title":"Mol Microbiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.exppara.2009.03.014","article-title":"Leishmania donovani lacking the Golgi GDP-man transporter LPG2 exhibit attenuated virulence in mammalian hosts","volume":"122","author":"Gaur","year":"2009","journal-title":"Exp Parasitol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1046\/j.1365-2958.2001.02286.x","article-title":"Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection","volume":"39","author":"Zhang","year":"2001","journal-title":"Mol Microbiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2199-6-3","article-title":"Role of Leishmania (Leishmania) chagasi amastigote cysteine protease in intracellular parasite survival: studies by gene disruption and antisense mRNA inhibition","volume":"6","author":"Mundodi","year":"2005","journal-title":"BMC Mol Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1074\/jbc.M110.138313","article-title":"The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion","volume":"286","author":"Swenerton","year":"2011","journal-title":"J Biol Chem"},{"key":"B73","doi-asserted-by":"publisher","first-page":"31120","DOI":"10.1074\/jbc.M110.114462","article-title":"Leishmania subtilisin is a maturase for the trypanothione reductase system and contributes to disease pathology","volume":"285","author":"Swenerton","year":"2010","journal-title":"J Biol Chem"},{"issue":"Pt 12","key":"B74","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1242\/jcs.064725","article-title":"Trafficking activity of myosin XXI is required in assembly of Leishmania flagellum","volume":"123","author":"Katta","year":"2010","journal-title":"J Cell Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e586","DOI":"10.1371\/journal.pntd.0000586","article-title":"Characterization of a subunit of the outer dynein arm docking complex necessary for correct flagellar assembly in Leishmania donovani","volume":"4","author":"Harder","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/mmi.12477","article-title":"An actin-like protein is involved in regulation of mitochondrial and flagellar functions as well as in intramacrophage survival of Leishmania donovani","volume":"91","author":"Singh","year":"2014","journal-title":"Mol Microbiol"},{"issue":"Pt 11","key":"B77","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1242\/jcs.113.11.2065","article-title":"LdARL-3A, a Leishmania promastigote-specific ADP-ribosylation factor-like protein, is essential for flagellum integrity","volume":"113","author":"Cuvillier","year":"2000","journal-title":"J Cell Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1756-3305-4-150","article-title":"Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation","volume":"4","author":"Carrion","year":"2011","journal-title":"Parasit Vectors"},{"key":"B79","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12192-009-0160-7","article-title":"The co-chaperone SGT of Leishmania donovani is essential for the parasite\u00e2\u20ac\u2122s viability","volume":"15","author":"Ommen","year":"2010","journal-title":"Cell Stress Chaperones"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e79287","DOI":"10.1371\/journal.pone.0079287","article-title":"Identification of a secreted casein kinase 1 in Leishmania donovani: effect of protein over expression on parasite growth and virulence","volume":"8","author":"Dan-Goor","year":"2013","journal-title":"PLoS One"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e6805","DOI":"10.1371\/journal.pone.0006805","article-title":"Glyoxalase I gene deletion mutants of Leishmania donovani exhibit reduced methylglyoxal detoxification","volume":"4","author":"Chauhan","year":"2009","journal-title":"PLoS One"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e25273","DOI":"10.1371\/journal.pone.0025273","article-title":"CYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovani","volume":"6","author":"Verma","year":"2011","journal-title":"PLoS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"10267","DOI":"10.1073\/pnas.92.22.10267","article-title":"Development of a safe live Leishmania vaccine line by gene replacement","volume":"92","author":"Titus","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B84","first-page":"455","article-title":"Genetically modified live attenuated parasites as vaccines for leishmaniasis","volume":"123","author":"Selvapandiyan","year":"2006","journal-title":"Indian J Med Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"B86","first-page":"27","article-title":"Visceral leishmaniasis: experimental models for drug discovery","volume":"133","author":"Gupta","year":"2011","journal-title":"Indian J Med Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e47907","DOI":"10.1371\/journal.pone.0047907","article-title":"Parasite burden in hamsters infected with two different strains of Leishmania (Leishmania) infantum: \u00e2\u20ac\u0153Leishman Donovan units\u00e2\u20ac\u009d versus real-time PCR","volume":"7","author":"Moreira","year":"2012","journal-title":"PLoS One"},{"key":"B88","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-3024.2008.01020.x","article-title":"Transgenic Leishmania and the immune response to infection","volume":"30","author":"Beattie","year":"2008","journal-title":"Parasite Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.vaccine.2012.02.016","article-title":"Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination","volume":"30","author":"Verheust","year":"2012","journal-title":"Vaccine"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1574-6968.12159","article-title":"Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update","volume":"344","author":"Leblanc","year":"2013","journal-title":"FEMS Microbiol Lett"},{"key":"B91","doi-asserted-by":"crossref","first-page":"461","DOI":"10.20452\/pamw.1117","article-title":"Therapeutic vaccines based on genetically modified Salmonella: a novel strategy in cancer immunotherapy","volume":"121","author":"Chorobik","year":"2011","journal-title":"Pol Arch Med Wewn"},{"key":"B92","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2583.2010.01000.x","article-title":"Flying vaccinator; a transgenic mosquito delivers a Leishmania vaccine via blood feeding","volume":"19","author":"Yamamoto","year":"2010","journal-title":"Insect Mol Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T22:29:49Z","timestamp":1746224989000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2014.00213\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":92,"URL":"https:\/\/doi.org\/10.3389\/fimmu.2014.00213","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}